SIRT1 and neuroblastoma: These findings therefore identify SIRT1 as an important co-factor for N-Myc oncogenesis, and provide important evidence for the potential application of SIRT1 inhibitors in the prevention and therapy of N-Myc-induced neuroblastoma.